Press Releases

Alere is leading the industry in informed, connected healthcare. Explore our news room to see how.

All
  • All
  • Corporate / Financial
  • Cardiometabolic
  • Connected Health
  • Health Information Solutions
  • Infectious Disease
  • Toxicology
  • Women's health
Date Press Release PDF
Dec 28
2016
Alere Provides Update on Arriva Medical
Dec 16
2016
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
Dec 07
2016
Alere Issues Statement Regarding Abbott Lawsuit
Nov 14
2016
Alere Provides Additional Information Regarding Arriva Medical On Its Website
Nov 13
2016
Arriva Medical and Centers for Medicare and Medicaid Services (CMS) Fact Sheet
Nov 04
2016
Alere Reports Third Quarter 2016 Financial Results
Oct 21
2016
Alere Shareholders Approve Merger with Abbott
Oct 20
2016
People’s Republic of China Clears Abbott Acquisition of Alere
Sep 14
2016
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
Sep 06
2016
Alere Reports Second Quarter 2016 Financial Results
Aug 26
2016
Alere Issues Statement
Aug 19
2016
Alere Receives FDA Clearance for Alere™ i RSV Rapid Molecular Test
Aug 17
2016
Alere Reports First Quarter 2016 Financial Results
Aug 09
2016
Alere Achieves IVD CE Mark for its Alere™ Reader Lateral Flow Assay Analyzer
Aug 08
2016
Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
Aug 01
2016
Alere Opens New Diagnostics Manufacturing Facility in India
Jul 27
2016
Alere Comments on Pain Management Subpoena
Jul 14
2016
Alere Inc. Announces Update on Form 10-K
Jul 13
2016
Alere™ HIV Combo Test Receives WHO Prequalification
Jul 11
2016
Alere to Initiate Voluntary Withdrawal of the Alere INRatio® and INRatio®2 PT/INR Monitoring System
Jul 06
2016
Alere Partners with BioIQ to Bring Advanced Biometric Screening Access to Hospitals, Health Plans, Pharmacies and Employers using the Alere Cholestech LDX® System
Jun 16
2016
Alere q HIV-1/2 Detect Point-of-Care Molecular HIV Assay Receives WHO Prequalification
Jun 11
2016
RGV ACO Health Provider, LLC Case Management Program, Including Point-of-Care HbA1c and Lipid Testing, Significantly Improved Outcomes for Diabetes Patients, according to Data Presented at American Diabetes Association
Jun 02
2016
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
May 10
2016
Alere Inc. Announces Successful Completion of Consent Solicitations for Alere’s Notes
May 05
2016
Alere Inc. Announces Modifications of Consent Solicitations for Alere Inc.’s Notes
Apr 29
2016
Alere Inc. Announces Commencement of Consent Solicitations for Alere Inc.’s Notes
Apr 28
2016
Alere Obtains Requisite Lender Approval for Extension to File Form 10-K; Announces Certain Developments Relating to the Pending Merger Transaction with Abbott Laboratories
Apr 11
2016
Innovative Partnership brings to Market New Tools for Neglected Tropical Diseases
Mar 21
2016
Alere Inc. Receives NYSE Notice Regarding Late Form 10-K Filing
Mar 18
2016
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
Mar 18
2016
Alere Comments on Alere Anticoagulation Monitoring Technology
Feb 19
2016
Alere to Report Fourth Quarter and Full Year 2015 Financial Results on February 26, 2016
Feb 01
2016
Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence
Jan 07
2016
Alere to Present at 34th Annual J.P. Morgan Healthcare Conference

Be Alerted

Stay alerted about our latest news and announcements

Sign Up

©2010-2015 Alere. All rights reserved. The Alere Logo and Alere are trademarks of the Alere group of companies. All other trademarks referenced are trademarks of their respective owners. This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Alere takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model.